Gene · 84335
Papers2,881
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,881
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma. | Pharmaceutics | 2023 | 37631344 | PubTator, text mining | PubMed |
| Three-Year Follow-Up after Intrauterine mTOR Inhibitor Administration for Fetus with TSC-Associated Rhabdomyoma. | Int J Mol Sci | 2023 | 37629066 | PubTator, text mining | PubMed |
| Signaling Pathways Leading to mTOR Activation Downstream Cytokine Receptors in Lymphocytes in Health and Disease. | Int J Mol Sci | 2023 | 37628917 | PubTator, text mining | PubMed |
| Endometriosis-Associated Ovarian Carcinomas: How PI3K/AKT/mTOR Pathway Affects Their Pathogenesis. | Biomolecules | 2023 | 37627318 | PubTator, text mining | PubMed |
| The Bone Microenvironment Soil in Prostate Cancer Metastasis: An miRNA Approach. | Cancers (Basel) | 2023 | 37627055 | PubTator, text mining | PubMed |
| Maternal metabolic status and in-vitro culture conditions during embryonic genome activation deregulate the expression of energy-related genes in the bovine 16-cells embryo. | PLoS One | 2023 | 37624829 | PubTator, text mining | PubMed |
| RNA modification: mechanisms and therapeutic targets. | Mol Biomed | 2023 | 37612540 | PubTator, text mining | PubMed |
| FGF1 supports glycolytic metabolism through the estrogen receptor in endocrine-resistant and obesity-associated breast cancer. | Breast Cancer Res | 2023 | 37608351 | PubTator, text mining | PubMed |
| Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphoma. | Front Immunol | 2023 | 37600821 | PubTator, text mining | PubMed |
| PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer. | Mol Cancer | 2023 | 37596643 | PubTator, text mining | PubMed |
| Regulation of CD8+ T memory and exhaustion by the mTOR signals. | Cell Mol Immunol | 2023 | 37582972 | PubTator, text mining | PubMed |
| Implication of mTOR Signaling in NSCLC: Mechanisms and Therapeutic Perspectives. | Cells | 2023 | 37566093 | PubTator, text mining | PubMed |
| Resolving the role of podoplanin in the motility of papillary thyroid carcinoma-derived cells using RNA sequencing. | Comput Struct Biotechnol J | 2023 | 37560122 | PubTator, text mining | PubMed |
| Cartilage-specific Sirt6 deficiency represses IGF-1 and enhances osteoarthritis severity in mice. | Ann Rheum Dis | 2023 | 37550003 | PubTator, text mining | PubMed |
| Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models. | NPJ Breast Cancer | 2023 | 37543694 | PubTator, text mining | PubMed |
| METTL14‑mediated RNA methylation in digestive system tumors. | Int J Mol Med | 2023 | 37539726 | PubTator, text mining | PubMed |
| Synthetic lethal approaches to target cancers with loss of PTEN function. | Genes Dis | 2023 | 37533462 | PubTator, text mining | PubMed |
| Methyltransferase-like proteins in cancer biology and potential therapeutic targeting. | J Hematol Oncol | 2023 | 37533128 | PubTator, text mining | PubMed |
| mTOR Signaling Pathway and Gut Microbiota in Various Disorders: Mechanisms and Potential Drugs in Pharmacotherapy. | Int J Mol Sci | 2023 | 37511569 | PubTator, text mining | PubMed |
| Regulation of mTOR Signaling: Emerging Role of Cyclic Nucleotide-Dependent Protein Kinases and Implications for Cardiometabolic Disease. | Int J Mol Sci | 2023 | 37511253 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84335/papers?page=8